ANI Pharmaceuticals Stock Forecast - Daily Balance Of Power
ANIP Stock | USD 59.39 1.53 2.64% |
ANI Stock Forecast is based on your current time horizon. Although ANI Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ANI Pharmaceuticals' systematic risk associated with finding meaningful patterns of ANI Pharmaceuticals fundamentals over time.
ANI |
Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
(0.15) | 0.1595 |
Check ANI Pharmaceuticals Volatility | Backtest ANI Pharmaceuticals | Trend Details |
ANI Pharmaceuticals Trading Date Momentum
On November 22 2024 ANI Pharmaceuticals was traded for 56.91 at the closing time. The top price for the day was 57.14 and the lowest listed price was 55.99 . The trading volume for the day was 131.8 K. The trading history from November 22, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 1.88% . The overall trading delta against the current closing price is 4.08% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare ANI Pharmaceuticals to competition |
Other Forecasting Options for ANI Pharmaceuticals
For every potential investor in ANI, whether a beginner or expert, ANI Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ANI Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ANI. Basic forecasting techniques help filter out the noise by identifying ANI Pharmaceuticals' price trends.ANI Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ANI Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of ANI Pharmaceuticals could also be used in its relative valuation, which is a method of valuing ANI Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
ANI Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ANI Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ANI Pharmaceuticals' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
ANI Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how ANI Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ANI Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying ANI Pharmaceuticals stock market strength indicators, traders can identify ANI Pharmaceuticals entry and exit signals to maximize returns.
ANI Pharmaceuticals Risk Indicators
The analysis of ANI Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ANI Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ani stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 1.9 | |||
Standard Deviation | 2.37 | |||
Variance | 5.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with ANI Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ANI Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ANI Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ANI Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ANI Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.